A potential link between muscle peroxisome proliferator- activated receptor-α signaling and obesity-related diabetes

Cell Metabolism

Volumn 1, Issue 2, 2005, Pages 133-144

  Finck, Brian N ^a   Bernal Mizrachi, Carlos ^a   Han, Dong Ho ^a   Coleman, Trey ^a   Sambandam, Nandakumar ^a   LaRiviere, Lori L ^a   Holloszy, John O ^a   Semenkovich, Clay F ^a   Kelly, Daniel P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; COMPLEMENTARY DNA; FATTY ACID; MESSENGER RNA; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DIET; EMBRYO; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE OVEREXPRESSION; GENE REPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; INSULIN RESISTANCE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; METABOLISM; MUSCLE; NORTHERN BLOTTING; PHENOTYPE; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; WESTERN BLOTTING;

MUS MUSCULUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; DIABETES MELLITUS; DNA, COMPLEMENTARY; FATTY ACIDS; GENE EXPRESSION REGULATION; GLUCOSE; INSULIN; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCLES; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXYGEN; PHENOTYPE; PHOSPHORYLATION; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 22544462381     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2005.01.006     Document Type: Article

References (45)

1. Backer J.M., Schroeder G.G., Kahn C.R., Myers Jr. M.G., Wilden P.A., Cahill D.A., and White M.F. Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation. J. Biol. Chem. 267 (1992) 1367-1374
2. Barnett M., Collier G.R., and O'Dea K. The longitudinal effect of inhibiting fatty acid oxidation in diabetic rats fed a high fat diet. Horm. Metab. Res. 24 (1992) 360-362
3. Bernal-Mizrachi C., Weng S., Li B., Nolte L.A., Feng C., Coleman T., Holloszy J.O., and Semenkovich C.F. Respiratory uncoupling lowers blood pressure through a leptin-dependent mechanism in genetically obese mice. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 961-968
4. Bernal-Mizrachi C., Weng S., Feng C., Finck B.N., Knutsen R.H., Leone T.C., Coleman T., Mecham R.P., Kelly D.P., and Semenkovich C.F. Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor-null mice. Nat. Med. 9 (2003) 1069-1075
5. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem. Sci. 29 (2004) 18-24
6. Collier G.R., Traianedes K., Macaulay S.L., and O'Dea K. Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats. Horm. Metab. Res. 25 (1993) 9-12
7. Cresci S., Wright L.D., Spratt J.A., Briggs F.N., and Kelly D.P. Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle. Am. J. Physiol. 270 (1996) C1413-C1420
8. Deschamps D., Fisch C., Fromenty B., Berson A., Degott C., and Pessayre D. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome. J. Pharmacol. Exp. Ther. 259 (1991) 894-904
9. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
10. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., Slezak L.A., Andersen D.K., Hundal R.S., Rothman D.L., et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103 (1999) 253-259
11. Engelgau M.M., Geiss L.S., Saaddine J.B., Boyle J.P., Benjamin S.M., Gregg E.W., Tierney E.F., Rios-Burrows N., Mokdad A.H., Ford E.S., et al. The evolving diabetes burden in the United States. Ann. Intern. Med. 140 (2004) 945-950
12. Finck B., Lehman J.J., Leone T.C., Welch M.J., Bennett M.J., Kovacs A., Han X., Gross R.W., Kozak R., Lopaschuk G.D., and Kelly D.P. The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109 (2002) 121-130
13. Finck B., Han X., Courtois M., Aimond F., Nerbonne J.M., Kovacs A., Gross R.W., and Kelly D.P. A critical role for PPAR α-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation of phenotype by dietary fat content. Proc. Natl. Acad. Sci. USA 100 (2003) 1226-1231
14. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., and Shulman G.I. Free fatty acid-induced insulin resistance is associated with activity of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48 (1999) 1270-1274
15. Guerre-Millo M., Gervois P., Raspe E., Madsen L., Poulain P., Derudas B., Herbert J.M., Winegar D.A., Willson T.M., Fruchart J.C., et al. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 275 (2000) 16638-16642
16. Guerre-Millo M., Rouault C., Poulain P., Andre J., Poitout V., Peters J.M., Gonzalez F.J., Fruchart J.C., Reach G., and Staels B. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50 (2001) 2809-2814
17. Han D.H., Nolte L.A., Ju J.S., Coleman T., Holloszy J.O., and Semenkovich C.F. UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E347-E353
18. Hansen P.A., Wang W., Marshall B.A., Holloszy J.O., and Mueckler M. Dissociation of GLUT4 translocation and insulin-stimulated glucose transport in transgenic mice overexpressing GLUT1 in skeletal muscle. J. Biol. Chem. 273 (1998) 18173-18179
19. Huss J.M., Pinéda Torra I., Staels B., Giguère V., and Kelly D.P. ERRα directs PPARα signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell. Biol. 24 (2004) 9079-9091
20. Jové M., Salla J., Planavila A., Cabrero A., Michalik L., Wahli W., Laguna J.C., and Vázquez-Carrera M. Impaired expression of NADH dehydrogenase subunit 1 and PPARγ coactivator-1 in skeletal muscle of ZDF rats: restoration by troglitazone. J. Lipid Res. 45 (2004) 113-123
21. Kelly D.P., Gordon J.I., Alpers R., and Strauss A.W. The tissue-specific expression and developmental regulation of the two nuclear genes encoding rat mitochondrial proteins: medium-chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J. Biol. Chem. 264 (1989) 18921-18925
22. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
23. Kim J.K., Fillmore J.J., Chen Y., Yu C., Moore I.K., Pypaert M., Lutz E.P., Kako Y., Velez-Carrasco W., Goldberg I.J., et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. USA 98 (2001) 7522-7527
24. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J., Yuan M., Li Z.W., Karin M., Perret P., et al. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108 (2001) 437-446
25. Kim H., Haluzik M., Asghar Z., Yau D., Joseph J.W., Fernandez A.M., Reitman M.L., Yakar S., Stannard B., Heron-Milhavet L., et al. Peroxisome proliferator-activated receptor-α agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes 52 (2003) 1770-1778
26. Lee S.S.T., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., and Gonzalez F.J. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15 (1995) 3012-3022
27. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARα) in the cellular fasting response: The PPARα -null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96 (1999) 7473-7478
28. Lowell B.B., Susulic V., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., Kozak L.P., and Flier J.S. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366 (1993) 740-742
29. Mandarino L., Tsalikian E., Bartold S., Marsh H., Carney A., Buerklin E., Tutwiler G., Haymond M., Handwerger B., and Rizza R. Mechanism of hyperglycemia and response to treatment with an inhibitor of fatty acid oxidation in a patient with insulin resistance due to antiinsulin receptor antibodies. J. Clin. Endocrinol. Metab. 59 (1984) 658-664
30. Michael L.F., Wu Z., Cheatham R.B., Puigserver P., Adelmant G., Lehman J.J., Kelly D.P., and Spiegelman B.M. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc. Natl. Acad. Sci. USA 98 (2001) 3820-3825
31. Mootha V.K., Lindgren C.M., Eriksson K.-F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (2003) 267-273
32. Mora S., and Pessin J.E. The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter. J. Biol. Chem. 275 (2000) 16323-16328
33. Mora S., Yang C., Ryder J.W., Boeglin D., and Pessin J.E. The MEF2A and MEF2D isoforms are differentially regulated in muscle and adipose tissue during states of insulin deficiency. Endocrinology 142 (2001) 1999-2004
34. Ojuka E.O. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc. Nutr. Soc. 63 (2004) 275-278
35. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 100 (2003) 8466-8471
36. Randle P.J., Hales C.N., and Garland P.B. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 (1963) 785-789
37. Saltiel A.R., and Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
38. Sambandam N., Steinmetz M., Chu A., Altarejos J.Y., Dyck J.R., and Lopaschuk G.D. Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5′ AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene trasfer technique. Eur. J. Biochem. 271 (2004) 2831-2840
39. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106 (2000) 171-176
40. Tordjman K., Bernal-Mizrachi C., Zemany L., Weng S., Feng C., Zhang F., Leone T.C., Coleman T., Kelly D.P., and Semenkovich C.F. Peroxisome proliferator-activated receptor α deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J. Clin. Invest. 107 (2001) 1025-1034
41. Tutwiler G.F., Kirsch T., Mohrbacher R.J., and Ho W. Pharmacologic profile of methyl 2-tetradecylglycidate (McN-3716)-an orally effective hypoglycemic agent. Metabolism 10 (1978) 1539-1556
42. Wang Y.-X., Zhang C.L., Yu R.T., Cho H.K., Nelson M.C., Bayuga-Ocampo C.R., Ham J., Kang H., and Evans R.M. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2 (2004) e294 10.1371/journal.pbio.0020294
43. Xu J., Chang V., Joseph S.B., Trujillo C., Bassilian S., Saad M.F., Lee W.N., and Kurland I.J. Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/pentose gene expression and substrate cycle flux. Endocrinology 145 (2004) 1087-1095
44. Yechoor V.K., Patti M.E., Saccone R., and Kahn C.R. Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc. Natl. Acad. Sci. USA 99 (2002) 10587-10592
45. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174